Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors

Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors

IntroductionCoronavirus Disease 2019 (COVID-19) is a severe respiratory illness caused by the RNA virus SARS-CoV-2. Globally, there have been over 759.4 million cases and 6.74 million deaths, while Ecuador has reported more than 1.06 million cases and 35.9 thousand deaths. To describe the COVID-19 p...

Full description

Bibliographic Details
Main Authors: Aníbal Gaviria, Rafael Tamayo-Trujillo, Elius Paz-Cruz, Santiago Cadena-Ullauri, Patricia Guevara-Ramírez, Viviana A. Ruiz-Pozo, Francisco Cevallos, Víctor Aguirre-Tello, Karla Risueño, Martha Paulina Yánez, Alejandro Cabrera-Andrade, Ana Karina Zambrano
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-06-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
COVID-19
seroprevalence
Ecuador
IgG
IgM
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1373450/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2024.1373450/full

Similar Items